Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-243002
Filing Date
2023-09-27
Accepted
2023-09-27 06:06:58
Documents
8
Period of Report
2023-09-27

Document Format Files

Seq Description Document Type Size
1 6-K d435214d6k.htm 6-K 9152
2 EX-99.1 d435214dex991.htm EX-99.1 23085
3 EX-99.2 d435214dex992.htm EX-99.2 22151
4 EX-99.3 d435214dex993.htm EX-99.3 31284
5 GRAPHIC g435214g0926061222931.jpg GRAPHIC 2601
6 GRAPHIC g435214g0926153952551.jpg GRAPHIC 2601
7 GRAPHIC g435214page4a.jpg GRAPHIC 3026
8 GRAPHIC g435214page4b.jpg GRAPHIC 1390
  Complete submission text file 0001193125-23-243002.txt   100689
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 231281750
SIC: 2834 Pharmaceutical Preparations